Contact
searchSearch
HMP Global

Clinical Pathways

Featured

BDHC thumbnail
Videos
Recognizing the Importance of Primary Care in Cancer Care Delivery
08/04/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the undervalued yet critical role of primary care in the health care ecosystem—especially in oncology—highlighting its impact on early detection,...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the undervalued yet critical role of primary care in the health care ecosystem—especially in oncology—highlighting its impact on early detection,...
In this episode of Breaking Down...
08/04/2025
Cancer Care Business Exchange
From Cancer Care Business Exchange
BDHC Thumbnail
Videos
What Medical School Doesn’t Teach: Real-World Readiness in US Health Care
06/11/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this edition of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the limitations of current medical education—from outdated testing and board certification to gaps in real-world practice preparedness—and call for...
In this edition of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the limitations of current medical education—from outdated testing and board certification to gaps in real-world practice preparedness—and call for...
In this edition of Breaking Down...
06/11/2025
Cancer Care Business Exchange
From Cancer Care Business Exchange
BDHC Thumbnail
Breaking Down Health Care
Navigating Payer Challenges in Cell and Gene Therapy
11/07/2024
Michael Kolodziej, MD; John Hennessy, MBA
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health...
11/07/2024
Cancer Care Business Exchange
From Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
Show Me the Medical Evidence
07/15/2024
Michael Kolodziej, MD; John Hennessy, MBA
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health...
07/15/2024
Cancer Care Business Exchange
From Cancer Care Business Exchange
JCP Flatiron Roundtable 1 Thumbnail
Videos
Oncology Care Pathways: Perspectives on Strategies and Best Practices
05/01/2024

Featuring Gordon Kuntz; Jeremy Drainville; James Hamrick, MD; Larry Shulman, MD; Bryan Loy, MD

Featuring Gordon Kuntz; Jeremy Drainv...
In this roundtable, participants discuss how to develop and implement clinical pathways at cancer centers. This includes integrating both the latest clinical evidence and payer contract requirements to develop the most efficient clinical...
In this roundtable, participants discuss how to develop and implement clinical pathways at cancer centers. This includes integrating both the latest clinical evidence and payer contract requirements to develop the most efficient clinical...
In this roundtable, participants...
05/01/2024
Journal of Clinical Pathways
From Journal of Clinical Pathways
Video thumbnail screenshot.
Videos
ONCare Alliance Merger Announcement: An Interview With Co-Founders Barbara McAneny, MD, and Sibel Blau, MD
03/11/2024

Featuring Barbara McAneny, MD, and Sibel Blau, MD

Featuring Barbara McAneny, MD, and Si...
Longtime industry leaders Barbara McAneny, MD, and Sibel Blau, MD, have joined forces to create ONCare Alliance, a strategic collaboration that aims to redefine the independent practice in community cancer care.
Longtime industry leaders Barbara McAneny, MD, and Sibel Blau, MD, have joined forces to create ONCare Alliance, a strategic collaboration that aims to redefine the independent practice in community cancer care.
Longtime industry leaders...
03/11/2024
Cancer Care Business Exchange
From Cancer Care Business Exchange
Stephen Speicher, MD
Videos
Safety and Quality Implications of Using Artificial Intelligence in Oncology
02/29/2024

Featuring Stephen V. Speicher, MD, MS

Featuring Stephen V. Speicher, MD, MS...
Stephen V. Speicher, MD, MS, previews his upcoming AMCCBS panel session titled “Deep Dive: Artificial and Business Intelligence Technology.”
Stephen V. Speicher, MD, MS, previews his upcoming AMCCBS panel session titled “Deep Dive: Artificial and Business Intelligence Technology.”
Stephen V. Speicher, MD, MS,...
02/29/2024
Journal of Clinical Pathways
From Journal of Clinical Pathways
Harlan Levine, MD
Videos
Expanding Access to Care Through Academic-Community Cancer Care Collaboration
01/23/2024
Harlan Levine, MD
Harlan Levine, MD, highlights the benefits of the collaboration between community cancer centers and academic medical centers, including allowing for more access to patient care.
Harlan Levine, MD, highlights the benefits of the collaboration between community cancer centers and academic medical centers, including allowing for more access to patient care.
Harlan Levine, MD, highlights...
01/23/2024
Journal of Clinical Pathways
From Journal of Clinical Pathways
Ivy Altomare, MD
Videos
Reimagining Clinical Trials in the Community Setting
10/20/2023
Ivy Altomare, MD
Ivy Altomare, MD, Flatiron Health, discusses the current state of clinical research in community oncology and how technologies and new models are changing clinical research.
Ivy Altomare, MD, Flatiron Health, discusses the current state of clinical research in community oncology and how technologies and new models are changing clinical research.
Ivy Altomare, MD, Flatiron...
10/20/2023
Journal of Clinical Pathways
From Journal of Clinical Pathways
Will Shapiro, Flatiron Health
Conference Coverage
The Future of AI in Cancer Care
10/08/2023
Will Shapiro
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of...
10/08/2023
Journal of Clinical Pathways
From Journal of Clinical Pathways
James Hamrick, MD
Conference Coverage
AI in Cancer Care: Separating Fact from Fiction
10/06/2023
James Hamrick, MD, MPH
James Hamrick, MD, discusses his presentation "AI in Cancer Care: Separating Fact from Fiction" at the 2023 Clinical Pathways Congress + Cancer Care Business Exchange meeting.
James Hamrick, MD, discusses his presentation "AI in Cancer Care: Separating Fact from Fiction" at the 2023 Clinical Pathways Congress + Cancer Care Business Exchange meeting.
James Hamrick, MD, discusses his...
10/06/2023
Journal of Clinical Pathways
From Journal of Clinical Pathways

Journal of Clinical Pathways

Research Reports
Effectiveness of Eribulin in Metastatic Breast Cancer Patients With Poor Prognostic Indicators in the United States
06/21/2021
Bruce A. Feinberg, DO; Talia Miller, MSW, MPH; Jingchuan Zhang, PhD; Marjorie E. Zettler, PhD, MPH; Sarah S. Mougalian, MD
A retrospective real-world study demonstrates the clinical effectiveness of eribulin in subgroups of MBC patients with poor prognostic characteristics, when used in accordance with the approved US indication.
A retrospective real-world study demonstrates the clinical effectiveness of eribulin in subgroups of MBC patients with poor prognostic characteristics, when used in accordance with the approved US indication.
A retrospective real-world study...
06/21/2021
Journal of Clinical Pathways
Research Reports
US Value-Based Management of Oncology Drugs: An Explorative Study of Payer and Provider Tools to Manage the Rising Spending on Oncology Drugs
06/21/2021
Oliver Walker, PhD; Daniele Severi-Bruni, MS; Anne Runyan, BA; Kolajo Salako, BS
Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.
Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.
Anne Runyan, BA , and colleagues...
06/21/2021
Journal of Clinical Pathways
Overactive Bladder Health Care Burden in the US Long-Term Care Setting: A Retrospective Cohort Study
Research Reports
Overactive Bladder Health Care Burden in the US Long-Term Care Setting: A Retrospective Cohort Study
05/18/2021
Drishti Shah, PhD; Jason Yeaw, MPH; Amy Kincaid, MA; Paul N. Mudd, Jr., PharmD, MBA; Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.
Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.
Richard Stefanacci, DO, and...
05/18/2021
Journal of Clinical Pathways
Assessing Clinician Attitudes and Beliefs Around Financial Toxicity Screening in Medical Oncology Clinic
Research Reports
Assessing Clinician Attitudes and Beliefs Around Financial Toxicity Screening in Medical Oncology Clinic
05/17/2021
Errol J. Philip, PhD; Lucky Ding; Sylvia T. Zhang, MS; Tracy Kuo Lin, MSc, PhD; Hala T. Borno, MD; Nichole Legaspi
Sylvia Zhang, MS, and colleagues discuss the attitudes, motivation, and experiences of clinicians regarding screening for financial toxicity in a medical oncology clinical setting, identifying potential opportunities for future clinician-led...
Sylvia Zhang, MS, and colleagues discuss the attitudes, motivation, and experiences of clinicians regarding screening for financial toxicity in a medical oncology clinical setting, identifying potential opportunities for future clinician-led...
Sylvia Zhang, MS, and colleagues...
05/17/2021
Journal of Clinical Pathways
Pediatric Sunscreen Coverage by Medicaid as a Primary Prevention Strategy to Reduce Melanoma Burden: A Cost-Effectiveness Analysis
Research Reports
Pediatric Sunscreen Coverage by Medicaid as a Primary Prevention Strategy to Reduce Melanoma Burden: A Cost-Effectiveness Analysis
04/22/2021
Christine T. Lauren, MD; Richard D. Carvajal, MD; Connor Stonesifer, BA; Chin Hur, MD, MPH; Robert Stern, MD; Daniel C. Malone, RPh, PhD, FAMCP; Larisa J. Geskin, MD; Megan H. Trager, MD; Dawn Queen, MD
Abstract: Melanoma treatment costs continue to rise. Sunscreen is a photoprotective tool that may reduce the incidence of melanoma but can be cost prohibitive for lower socioeconomic populations. New York State...
Abstract: Melanoma treatment costs continue to rise. Sunscreen is a photoprotective tool that may reduce the incidence of melanoma but can be cost prohibitive for lower socioeconomic populations. New York State...
...
04/22/2021
Journal of Clinical Pathways
Patient Voices in Value-Based Cancer Care: Priorities for the Biden Administration
Perspectives
Patient Voices in Value-Based Cancer Care: Priorities for the Biden Administration
04/22/2021
Jacqlyn Riposo, MBA; Mark McClellan, MD, PhD; Kimberly Westrich, MA; Ethan Basch, MD, MSc; Tom Valuck, MD, JD; Theresa Schmidt, MA, PMP, CSPO
Abstract: The Biden administration has an opportunity to prioritize patient perspectives in innovative value-based payment models for oncology by incorporating meaningful patient-reported measures (PRMs) and...
Abstract: The Biden administration has an opportunity to prioritize patient perspectives in innovative value-based payment models for oncology by incorporating meaningful patient-reported measures (PRMs) and...
...
04/22/2021
Journal of Clinical Pathways

Oncology Clinical Pathways Congress

Conference Coverage
Real-World Evidence in Oncology: Opportunities, Challenges, and Clinical Impact
09/10/2025
Grace Taylor, MS, MA
In this CPC+CBEx session, experts debate how real-world evidence can complement clinical trials, accelerate regulatory approvals, and reshape patient care.
In this CPC+CBEx session, experts debate how real-world evidence can complement clinical trials, accelerate regulatory approvals, and reshape patient care.
In this CPC+CBEx session,...
09/10/2025
Journal of Clinical Pathways
Conference Coverage
Building a Transparent Framework for Predictable Cost of Care in Oncology Pathways
09/10/2025
Hannah Musick
The Predictable Cost of Care initiative is creating a transparent, standardized model to quantify the true, incremental costs of cancer therapies—enabling more informed, equitable, and efficient decision-making across pathways, payers, and...
The Predictable Cost of Care initiative is creating a transparent, standardized model to quantify the true, incremental costs of cancer therapies—enabling more informed, equitable, and efficient decision-making across pathways, payers, and...
The Predictable Cost of Care...
09/10/2025
Journal of Clinical Pathways
Conference Coverage
Reviewing a Decade of Oncology Pathways: Standardization, Gaps, and the Road to Real-Time Intelligence
09/09/2025
Hannah Musick
A decade after the American Society of Clinical Oncology’s (ASCO’s) original guidance, oncology pathways are maturing into powerful tools for standardizing care, but gaps in disease coverage, workflow integration, and real-time adaptability...
A decade after the American Society of Clinical Oncology’s (ASCO’s) original guidance, oncology pathways are maturing into powerful tools for standardizing care, but gaps in disease coverage, workflow integration, and real-time adaptability...
A decade after the American...
09/09/2025
Journal of Clinical Pathways
Conference Coverage
How AI is Reshaping Clinical Practice, Governance, and Patient Trust
09/09/2025
Grace Taylor, MS, MA
From streamlining documentation to reshaping prior authorization, a panel of experts reveal how artificial intelligence (AI) is changing the realities of cancer care—and the challenges that come with it.
From streamlining documentation to reshaping prior authorization, a panel of experts reveal how artificial intelligence (AI) is changing the realities of cancer care—and the challenges that come with it.
From streamlining documentation...
09/09/2025
Journal of Clinical Pathways
Conference Coverage
From Dispensing to Decision-Making: How Pharmacists Are Redefining Leadership in Oncology Care
09/08/2025
Grace Taylor, MS, MA
This session highlights how pharmacists are stepping into pivotal leadership roles, balancing science, business, and patient care to navigate the increasingly complex oncology treatment landscape.
This session highlights how pharmacists are stepping into pivotal leadership roles, balancing science, business, and patient care to navigate the increasingly complex oncology treatment landscape.
This session highlights how...
09/08/2025
Journal of Clinical Pathways
Conference Coverage
Theranostics: Clinical Promise, Operational Hurdles, and the Road Ahead
09/08/2025
Hannah Musick
Theranostics is rapidly emerging as a transformative, fifth pillar of cancer care—combining precision imaging and targeted radiopharmaceutical therapy—but its widespread adoption hinges on overcoming operational, financial, and infrastructure...
Theranostics is rapidly emerging as a transformative, fifth pillar of cancer care—combining precision imaging and targeted radiopharmaceutical therapy—but its widespread adoption hinges on overcoming operational, financial, and infrastructure...
Theranostics is rapidly emerging...
09/08/2025
Journal of Clinical Pathways
Conference Coverage
Scaling Bispecifics and CAR T-Cell Therapy in Community Oncology: From Promise to Practice
09/08/2025
Hannah Musick
A panel of oncology leaders urged community practices to take immediate, systematized steps to adopt bispecifics and CAR T-cell therapies—highlighting that without local access, the promise of these innovations may never reach the patients...
A panel of oncology leaders urged community practices to take immediate, systematized steps to adopt bispecifics and CAR T-cell therapies—highlighting that without local access, the promise of these innovations may never reach the patients...
A panel of oncology leaders...
09/08/2025
Journal of Clinical Pathways
News
Policy and Payment Shifts on the Horizon: Navigating Uncertainty in Cancer Care
09/08/2025
Hannah Musick
A sweeping policy and payment update at the conference revealed mounting pressure across Medicaid, Medicare, and employer markets—posing new risks and strategic imperatives for oncology providers navigating a rapidly shifting health care...
A sweeping policy and payment update at the conference revealed mounting pressure across Medicaid, Medicare, and employer markets—posing new risks and strategic imperatives for oncology providers navigating a rapidly shifting health care...
A sweeping policy and payment...
09/08/2025
Journal of Clinical Pathways
Conference Coverage
Practical Insights for Embedding Whole-Person Care into Clinical Pathways
09/08/2025
Juliet Gallagher
A session at CPC+CBEx 2025 highlighted how structured triage, real-time care coordination, and non-clinical staff training can transform symptom management and reduce unnecessary acute care utilization in oncology.
A session at CPC+CBEx 2025 highlighted how structured triage, real-time care coordination, and non-clinical staff training can transform symptom management and reduce unnecessary acute care utilization in oncology.
A session at CPC+CBEx 2025...
09/08/2025
Journal of Clinical Pathways
Conference Coverage
Reinventing Health Care: Tom Koulopoulos on AI, Behavioral Shifts, and the Human Future of Medicine
09/08/2025
Grace Taylor, MS, MA
In his keynote address, Thomas Koulopoulos argues that the true future of health care lies not in technology alone but in reimagining human behaviors to create a seamless, patient-driven system empowered by artificial intelligence (AI).
In his keynote address, Thomas Koulopoulos argues that the true future of health care lies not in technology alone but in reimagining human behaviors to create a seamless, patient-driven system empowered by artificial intelligence (AI).
In his keynote address, Thomas...
09/08/2025
Journal of Clinical Pathways

CME

Multimedia

BDHC thumbnail
Videos
Recognizing the Importance of Primary Care in Cancer Care Delivery
08/04/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the undervalued yet critical role of primary care in the health care ecosystem—especially in oncology—highlighting its impact on early detection,...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the undervalued yet critical role of primary care in the health care ecosystem—especially in oncology—highlighting its impact on early detection,...
In this episode of Breaking Down...
08/04/2025
Cancer Care Business Exchange
BDHC Thumbnail
Videos
What Medical School Doesn’t Teach: Real-World Readiness in US Health Care
06/11/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this edition of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the limitations of current medical education—from outdated testing and board certification to gaps in real-world practice preparedness—and call for...
In this edition of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the limitations of current medical education—from outdated testing and board certification to gaps in real-world practice preparedness—and call for...
In this edition of Breaking Down...
06/11/2025
Cancer Care Business Exchange
BDHC Thumbnail
Videos
Evolving Remote Engagement in Oncology: Beyond the Telehealth Visit
05/05/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej discuss the evolution of remote patient engagement in oncology—from the rapid expansion of telemedicine during COVID-19 to the growing role of tools like...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej discuss the evolution of remote patient engagement in oncology—from the rapid expansion of telemedicine during COVID-19 to the growing role of tools like...
In this episode of Breaking Down...
05/05/2025
Cancer Care Business Exchange
BDHC Thumbnail
Videos
When Capital Meets Care: Examining the Role of Private Equity in Oncology
04/07/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Dr Michael Kolodziej, MD, explore the complex and evolving role of private equity in health care, weighing its potential to drive innovation and efficiency against concerns...
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Dr Michael Kolodziej, MD, explore the complex and evolving role of private equity in health care, weighing its potential to drive innovation and efficiency against concerns...
In this episode of Breaking Down...
04/07/2025
Cancer Care Business Exchange
BDHC Thumbnail
Videos
Expanding Access to Clinical Trials: What Oncologists and Payers Need to Know
02/28/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Michael Kolodziej, MD, explore the evolving landscape of oncology clinical trials, discussing the challenges of patient enrollment, the impact of pharmaceutical-sponsored...
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Michael Kolodziej, MD, explore the evolving landscape of oncology clinical trials, discussing the challenges of patient enrollment, the impact of pharmaceutical-sponsored...
In this episode of Breaking Down...
02/28/2025
Cancer Care Business Exchange
BDHC Thumbnail
Videos
Alternative Payment Models in Health Care: Successes, Failures, and What’s Next
01/09/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the evolution and challenges of alternative payment models, including accountable care organizations (ACOs), the Oncology Care Model (OCM),...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the evolution and challenges of alternative payment models, including accountable care organizations (ACOs), the Oncology Care Model (OCM),...
In this Breaking Down Health...
01/09/2025
Cancer Care Business Exchange
BDHC thumbnail
Videos
Precision Medicine in Oncology: From Testing to Therapy
12/05/2024
John Hennessy, MBA; Michael Kolodziej, MD
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, explore the distinction between precision and personalized medicine, the challenges and nuances of next-generation sequencing (NGS) testing in...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, explore the distinction between precision and personalized medicine, the challenges and nuances of next-generation sequencing (NGS) testing in...
In this Breaking Down Health...
12/05/2024
Cancer Care Business Exchange
BDHC Thumbnail
Breaking Down Health Care
Navigating Payer Challenges in Cell and Gene Therapy
11/07/2024
Michael Kolodziej, MD; John Hennessy, MBA
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health...
11/07/2024
Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
The Government and Health Care: A Volatile or Necessary Mix? (Part II)
08/22/2024
John Hennessy, MBA; Michael Kolodziej, MD
In the second part of this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, cover the US federal government’s role in health care—Medicare, Medicaid, and the Affordable Care Act. They discuss the...
In the second part of this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, cover the US federal government’s role in health care—Medicare, Medicaid, and the Affordable Care Act. They discuss the...
In the second part of this...
08/22/2024
Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
Why People Should Care About How Health Care Works (Part 1)
07/29/2024
Michael Kolodziej, MD; John Hennessy, MBA
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.
In part one of this two-part...
07/29/2024
Cancer Care Business Exchange

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use